Natural Products as a Promising Therapeutic Strategy to Target Cancer Stem Cells

Merve Erkisa1, Melda Sariman1, Oyku Gonul Geyik1,2

  • 1Molecular Cancer Research Center (ISUMKAM), Istinye University, Istanbul, Turkey.

Insights

Natural products offer a promising, cost-effective strategy to combat cancer stem cells (CSCs), which drive cancer recurrence and treatment resistance. Research explores how these compounds can be developed into novel, affordable anticancer drugs.

Area of Science:

  • Oncology
  • Pharmacology
  • Natural Products Chemistry

Background:

  • Cancer recurrence is often attributed to cancer stem cells (CSCs), a resistant subpopulation.
  • CSCs exhibit uncontrolled self-renewal, proliferation, and resistance to conventional therapies and immune surveillance.
  • Current CSC treatments are expensive, necessitating the search for affordable alternatives.

Purpose of the Study:

  • To review the mechanisms by which natural compounds eliminate cancer stem cells (CSCs).
  • To explore the potential of natural products as a source for novel, cost-effective anticancer therapies.
  • To highlight research on natural compounds targeting CSCs for improved cancer treatment.

Main Methods:

  • Review of preclinical and clinical research on natural compounds and CSCs.
  • Analysis of studies investigating natural products' effects on CSC surface markers and signaling pathways.
  • Examination of research on natural compounds' impact on apoptosis and immune evasion in CSCs.

Main Results:

  • Natural products represent a diverse chemical library with potential to suppress CSCs.
  • Several natural compounds show promise in targeting CSCs through various mechanisms.
  • Research indicates natural compounds can affect CSCs' surface markers, signaling pathways, and apoptosis.

Conclusions:

  • Natural products offer a viable and potentially affordable alternative to current expensive cancer therapies.
  • Further research into natural compounds could lead to the development of new drugs targeting cancer stem cells.
  • Harnessing natural products may provide novel strategies to overcome CSC-mediated cancer recurrence and resistance.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.0K
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.3K
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
5.2K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.3K